News & Updates
Filter by Specialty:
FOLFIRINOX safe, effective in older adults with advanced pancreatic cancer
The combination therapy of 5-fluorouracil, irinotecan, leucovorin, and oxaliplatin (FOLFIRINOX) improves response and overall survival (OS) in older adults with advanced pancreatic cancer (APC), a recent study has shown.
FOLFIRINOX safe, effective in older adults with advanced pancreatic cancer
14 Feb 2022
No benefit to adding 5-ASAs to steroids in acute severe UC
The addition of 5-aminosalicylic acid (5-ASA) to standard corticosteroid treatment did not improve outcomes in patients hospitalized with acute severe ulcerative colitis (UC), according to a study presented at the Crohn’s and Colitis Congress 2022.
No benefit to adding 5-ASAs to steroids in acute severe UC
11 Feb 2022
Which factor impels offering of postoperative chemotherapy in nonmuscle invasive bladder cancer?
A recent study has shown clear preferences by urologists when providing postoperative immediate chemotherapy in nonmuscle invasive bladder cancer (NMIBC). Factors beyond clinical variables, such as the structure of the recovery room, play a role in this decision-making process.
Which factor impels offering of postoperative chemotherapy in nonmuscle invasive bladder cancer?
11 Feb 2022
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
The risk of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) was substantially reduced among girls who were offered the bivalent human papillomavirus (HPV) vaccine, particularly those who were offered it at age 12–13 years, according to an observational study from England.